Evidence map›Paper›PMID 30372681›Full record

ArticleJournal of Alzheimer's disease : JAD2018

DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer's Disease.

Andy Madrid, Kirk J Hogan, Ligia A Papale, Lindsay R Clark, Sanjay Asthana, Sterling C Johnson, Reid S Alisch

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Blood DNA Methylation Predicts Long-Term Risk of Dementia in Prospective Cohorts.medRxiv : the preprint server for health sciences · 2026
    Article
  4. Article
  5. Article
  6. Blood DNA methylation signature for incident dementia: Evidence from longitudinal cohorts.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Andy MadridDepartment of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Kirk J HoganDepartment of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Ligia A PapaleDepartment of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Lindsay R ClarkWisconsin Alzheimer's Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Sanjay AsthanaWisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Sterling C JohnsonWisconsin Alzheimer's Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Reid S AlischDepartment of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
University of Wisconsin–Madison · USGeriatric Research Education and Clinical Center · USWilliam S. Middleton Memorial Veterans Hospital · US

Funding

Wisconsin Registry for Alzheimer's Prevention: Sex Differences in DNA MethylationR01AG027161 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Nathaniel Ark Chin, Sterling C Johnson · 2007 to 2026
$35.6M
Wisconsin Registry for Alzheimer's PreventionRF1AG027161 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI JOHNSON, STERLING C · 2018 to 2018
$18.8M
Wisconsin Alzheimer's Disease Research CenterP50AG033514 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI ASTHANA, SANJAY · 2009 to 2018
$16.2M
Defining the Molecular Origins of Developmental Brain DisordersF31MH113351 · NIMH · UNIVERSITY OF WISCONSIN-MADISON · PI MADRID, ANDY · 2017 to 2019
$98k
NIA NIH HHS P50 AG033514NIA NIH HHS R01 AG027161NIA NIH HHS RF1 AG027161NIMH NIH HHS F31 MH113351
6 · The paper itself

Abstract

Differentially methylated positions (DMPs) between persons with and without late-onset Alzheimer's disease (LOAD) were observed at 477 of 769,190 loci in a plurality of genes. Of these, 17 were shared with DMPs identified using clinical LOAD markers analyzed independently as continuous variables comprising Rey Auditory Verbal Learning Test scores, cerebrospinal fluid total tau (t-tau) and phosphorylated tau 181 (p-tau181) levels, and t-tau/Aβ1-42 (Aβ42), p-tau181/Aβ42, and Aβ42/Aβ1-40 (Aβ40) ratios. In patients with LOAD, 12 of the shared 17 DMPs were hypomethylated in B3GALT4 (Beta-1,3-galatcosyltransferase 4) (EC 2.4.1.62), and 5 were hypomethylated in ZADH2 (Prostaglandin reductase 3) (EC 1.3.1.48).

Indexed as

DNA MethylationAgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesAntigens, SurfaceCognitive DysfunctionGalactosyltransferasesHumansMemory and Learning TestsPeptide FragmentsPhosphorylationtau ProteinsTrail Making TestAmyloid beta-PeptidesAntigens, SurfaceGalactosyltransferasesPeptide Fragmentstau ProteinsUDP-Gal-betaGlcNAc beta 1,3-galactosyltransferase, humanZADH2 protein, humanAmyloidDNA methylationlate-onset Alzheimer’s diseasetau proteins

Identifiers

PMID30372681
PMCPMC6478383
OpenAlexW2897442393

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.